Ledger.Open graph →
SEC Form D · Amendment · filed November 23, 2021

Magnolia Neurosciences Corp

Offering
$18.4M
Sold
$18.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Steve Gillis · New York, NYDirectorKendall Mohler · New York, NYExecAlice J. Ly · New York, NYDirectorMichael J. Baran · New York, NYDirectorIan Howes · New York, NYExecThong Le · New York, NYExec · DirectorDean I. Sutton · Vancouver, British Columbia, CanadaExec · DirectorAdele Gorrilla · Philadelphia, PAExecJohn Mcmahon · SAN FRANCISCO, CADirectorSheona I. Docksteader · Vancouver, British Columbia, CanadaDirectorSteven I. Krause · Vancouver, British Columbia, CanadaExecBill I. Koutsouras · Vancouver, British Columbia, CanadaDirectorRoger Mills · Geneva, V8ExecMikhail Kalinichev · Geneva, V8Exec · DirectorJake Nunn · Menlo Park, CADirectorJean-Philippe Rocher · Geneva, V8DirectorIsaac Manke · New York, NYExecMartin Dolfi · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗